John Paulson Acquires 1,005,376 Shares of Bausch Health Companies Inc. (NYSE:BHC) Stock

Bausch Health Companies Inc. (NYSE:BHC - Get Free Report) Director John Paulson acquired 1,005,376 shares of Bausch Health Companies stock in a transaction dated Thursday, June 12th. The stock was acquired at an average cost of $5.47 per share, with a total value of $5,499,406.72. Following the completion of the transaction, the director now directly owns 29,227,643 shares of the company's stock, valued at $159,875,207.21. This trade represents a 3.56% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

John Paulson also recently made the following trade(s):

• On Wednesday, June 11th, John Paulson acquired 1,029,098 shares of Bausch Health Companies stock. The shares were bought at an average cost of $5.24 per share, with a total value of $5,392,473.52.
• On Tuesday, June 10th, John Paulson bought 754,134 shares of Bausch Health Companies stock. The shares were purchased at an average cost of $5.05 per share, for a total transaction of $3,808,376.70.

Bausch Health Companies Stock Up 9.2%

Bausch Health Companies stock traded up $0.51 during mid-day trading on Friday, hitting $6.02. 11,490,808 shares of the company were exchanged, compared to its average volume of 2,611,854. The company has a market capitalization of $2.23 billion, a PE ratio of -50.12, a price-to-earnings-growth ratio of 0.37 and a beta of 0.28. The business has a fifty day moving average of $4.85 and a 200 day moving average of $6.42. Bausch Health Companies Inc. has a 1-year low of $3.96 and a 1-year high of $9.85.

Hedge Funds Weigh In On Bausch Health Companies

Institutional investors have recently added to or reduced their stakes in the company. SBI Securities Co. Ltd. grew its holdings in shares of Bausch Health Companies by 244.2% during the first quarter. SBI Securities Co. Ltd. now owns 4,230 shares of the company's stock worth $27,000 after purchasing an additional 3,001 shares during the last quarter. Cary Street Partners Financial LLC acquired a new position in Bausch Health Companies during the 1st quarter worth about $27,000. Caitong International Asset Management Co. Ltd bought a new stake in Bausch Health Companies during the 1st quarter worth about $27,000. Mountain Hill Investment Partners Corp. acquired a new stake in Bausch Health Companies in the 4th quarter valued at about $56,000. Finally, Wealthquest Corp acquired a new stake in Bausch Health Companies in the 1st quarter valued at about $58,000. 78.65% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several research firms have commented on BHC. Royal Bank of Canada upped their price target on Bausch Health Companies from $8.50 to $10.00 and gave the company a "sector perform" rating in a report on Friday, May 2nd. Wall Street Zen cut Bausch Health Companies from a "buy" rating to a "hold" rating in a research report on Saturday, May 10th. One research analyst has rated the stock with a sell rating and seven have given a hold rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus price target of $7.42.

Bausch Health Companies Company Profile

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.